Abstract
Background: Brain subependymal giant cell astrocytomas (SEGAs) in patients with tuberous sclerosis have been reported to respond to everolimus.
Methods: A 15-year-old male patient with intractable seizures and multiple SEGAs of the brain developed leptomeningeal enhancement and multiple metastatic, histologically confirmed SEGAs of the spinal cord. He received daily everolimus at a dose of 3 mg/m2 for 6 weeks, which was then increased to 6 mg/m2.
Results: Magnetic resonance image of the brain and spine showed significant reduction in the size of SEGAs after 6 weeks of treatment. The patient has remained free of progression for 24 months. Additional benefits included: excellent seizure control, decrease in the size of cardiac rhabdomyomas, and improved quality of life.
Conclusions: We describe a rare case of metastatic SEGA, which was successfully treated with everolimus.
| Original language | English |
|---|---|
| Pages (from-to) | e448-e451 |
| Journal | Journal of Pediatric Hematology/Oncology |
| Volume | 36 |
| Issue number | 7 |
| DOIs | |
| State | Published - 8 Oct 2014 |
Keywords
- Everolimus
- SEGA
- Spinal cord
- Tuberous sclerosis
Fingerprint
Dive into the research topics of 'Response of subependymal giant cell astrocytoma with spinal cord metastasis to everolimus'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver